BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23196058)

  • 1. Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer.
    Roberts NJ; Klein AP
    Cancer Lett; 2013 Nov; 340(2):227-33. PubMed ID: 23196058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic sequencing in cancer.
    Tuna M; Amos CI
    Cancer Lett; 2013 Nov; 340(2):161-70. PubMed ID: 23178448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.
    Patel LR; Nykter M; Chen K; Zhang W
    Cancer Lett; 2013 Nov; 340(2):152-60. PubMed ID: 23111104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing in the clinic: promises and challenges.
    Xuan J; Yu Y; Qing T; Guo L; Shi L
    Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying molecular drivers of gastric cancer through next-generation sequencing.
    Liang H; Kim YH
    Cancer Lett; 2013 Nov; 340(2):241-6. PubMed ID: 23178814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing the cancer methylome through targeted bisulfite sequencing.
    Lee EJ; Luo J; Wilson JM; Shi H
    Cancer Lett; 2013 Nov; 340(2):171-8. PubMed ID: 23200671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncovering Hereditary Tumor Syndromes: Emerging Role of Surgical Pathology.
    Agaimy A; Hartmann A
    Semin Diagn Pathol; 2018 May; 35(3):154-160. PubMed ID: 29395463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion genes and their discovery using high throughput sequencing.
    Annala MJ; Parker BC; Zhang W; Nykter M
    Cancer Lett; 2013 Nov; 340(2):192-200. PubMed ID: 23376639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition to pancreatic cancer.
    Ghiorzo P
    World J Gastroenterol; 2014 Aug; 20(31):10778-89. PubMed ID: 25152581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.
    Kasuga A; Okamoto T; Udagawa S; Mori C; Mie T; Furukawa T; Yamada Y; Takeda T; Matsuyama M; Sasaki T; Ozaka M; Ueki A; Sasahira N
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of Familial and Sporadic Pancreatic Cancer.
    Wood LD; Yurgelun MB; Goggins MG
    Gastroenterology; 2019 May; 156(7):2041-2055. PubMed ID: 30660730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next generation immunohistochemistry: Emerging substitutes to genetic testing?
    Andrici J; Gill AJ; Hornick JL
    Semin Diagn Pathol; 2018 May; 35(3):161-169. PubMed ID: 28662997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
    Li S; Mao M
    Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive genome sequencing of the liver cancer genome.
    Nakagawa H; Shibata T
    Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
    Stoffel EM; McKernin SE; Brand R; Canto M; Goggins M; Moravek C; Nagarajan A; Petersen GM; Simeone DM; Yurgelun M; Khorana AA
    J Clin Oncol; 2019 Jan; 37(2):153-164. PubMed ID: 30457921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances for studying clonal evolution in cancer.
    Ding L; Raphael BJ; Chen F; Wendl MC
    Cancer Lett; 2013 Nov; 340(2):212-9. PubMed ID: 23353056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer omics: from regulatory networks to clinical outcomes.
    Tang B; Hsu PY; Huang TH; Jin VX
    Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics of the AmpliSeq Cancer Hotspot panel v2 in combination with the Ion Torrent Next Generation Sequencing Personal Genome Machine.
    Butler KS; Young MY; Li Z; Elespuru RK; Wood SC
    Regul Toxicol Pharmacol; 2016 Feb; 74():178-86. PubMed ID: 26387931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.